Simplex Trading
EVOK

Simplex Trading’s Evoke Pharma EVOK Stock Holding History

Simplex Trading’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-83
Closed -$6K – 10652
2021
Q4 		$6K Sell
83
-1,441
-95% -$202K ﹤0.01% 9403
2021
Q3 		$289K Sell
1,524
-3
-0.2% -$506 ﹤0.01% 4960
2021
Q2 		$301K Buy
1,527
+1,511
+9,444% +$324K ﹤0.01% 4981
2021
Q1 		$418K Buy
16
+6
+60% +$2.4K ﹤0.01% 3635
2020
Q4 		$380K Buy
10
+3
+43% +$1.55K ﹤0.01% 3789
2020
Q3 		$495K Buy
+7
New +$4.46K ﹤0.01% 3011

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading's EVOK Position: Q2 2022 in Review

Simplex Trading sold out of Evoke Pharma (EVOK) in Q2 2022, closing a stake of 21 shares — an estimated $1K sold.

Simplex Trading first reported a position in EVOK in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 12 funds tracked by Wall St. Rank hold EVOK as of Q2 2022.

  • Simplex Trading reported no remaining Evoke Pharma position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 21 Evoke Pharma shares in Q2 2022, an estimated $1K.
  • Simplex Trading first reported a position in Evoke Pharma in Q4 2021 and held it in 2 quarters.
  • Simplex Trading's Evoke Pharma position peaked at $1K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.